ArticleJCO precision oncology2025

Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal Adenocarcinoma.

Stephane Wenric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.